What is the management and treatment of placenta accreta in a pregnant patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management and Treatment of Placenta Accreta Spectrum

The definitive treatment for placenta accreta spectrum is planned cesarean hysterectomy with the placenta left in situ, performed at 34 0/7 to 35 6/7 weeks gestation at a level III or IV maternal care facility with a multidisciplinary team, because attempting to remove the placenta causes catastrophic hemorrhage. 1

Delivery Timing

Deliver between 34 0/7 and 35 6/7 weeks of gestation for stable patients. 2, 1 This narrow window exists because:

  • Waiting beyond 36 weeks results in approximately 50% of patients requiring emergent delivery for hemorrhage 2, 1
  • Earlier delivery increases neonatal morbidity from prematurity 1
  • Administer antenatal corticosteroids when delivery is planned before 37 weeks 1

Facility Requirements

Delivery must occur at a level III or IV maternal care facility with the following immediately available resources 2, 1:

  • Maternal-fetal medicine subspecialists 1
  • Experienced pelvic surgeons 1
  • Urologists 1
  • Interventional radiologists 1
  • Obstetric anesthesiologists 1
  • Critical care specialists 1
  • Blood bank with massive transfusion protocols 3, 2, 1
  • ICU capabilities 2, 1

This level of care is essential because placenta accreta spectrum is considered a high-risk condition with serious associated morbidities, including severe hemorrhage, increased maternal mortality, and frequent need for hysterectomy. 3

Preoperative Optimization

Maximize hemoglobin values before delivery using oral or intravenous iron supplementation 1. Additional preoperative steps include:

  • Verify exact surgical suite location and capabilities 1
  • Confirm all necessary consultations have occurred 1
  • Notify the blood bank in advance of scheduled delivery 1
  • Consider ureteric stent placement if bladder involvement is suspected 1

Surgical Technique

The standard approach is cesarean hysterectomy with the placenta left in place rather than attempting placental delivery, which causes catastrophic hemorrhage. 3, 2, 1, 4 The surgical steps are:

  • Make the uterine incision away from the placenta when possible 1
  • Deliver the fetus 1
  • Leave the placenta in situ—do not attempt removal 1, 4
  • Proceed immediately to hysterectomy 1

Critical Intraoperative Management

Activate massive transfusion protocol early without waiting for laboratory confirmation if significant bleeding is present 1. Additional intraoperative measures include:

  • Maintain patient temperature >36°C, as clotting factors function poorly at lower temperatures 1
  • Consider tranexamic acid to reduce blood loss 1
  • Re-dose prophylactic antibiotics if blood loss exceeds 1,500 mL 1
  • Monitor baseline coagulation studies 1

Management of Unexpected Diagnosis at Delivery

If placenta accreta spectrum is encountered unexpectedly without prior diagnosis, immediately pause the case. 1 Then:

  • Alert anesthesia 1
  • Mobilize optimal surgical expertise 1
  • Transfer the patient to a facility capable of performing cesarean hysterectomy if necessary 1
  • Never attempt manual placental removal 1

This scenario represents a critical pitfall, as placenta accreta spectrum is underdiagnosed and can result in massive hemorrhage, disseminated intravascular coagulation, surgical injury, multisystem organ failure, and death. 5

Postoperative Care

Transfer to ICU for intensive hemodynamic monitoring. 1 Specific monitoring includes:

  • Maintain vigilance for ongoing bleeding with a low threshold for reoperation 1
  • Monitor for complications including ongoing bleeding, fluid overload, renal failure, and liver failure 1
  • Watch for Sheehan syndrome (postpartum pituitary necrosis) in cases with significant hypoperfusion 1

Conservative (Uterine-Sparing) Management

Conservative management should be considered investigational and only attempted in carefully selected cases after detailed counseling about uncertain benefits and significant risks. 1 This approach carries a 28.6% recurrence risk in subsequent pregnancies. 1

Critical Pitfalls to Avoid

Never perform the following actions 1:

  • Never attempt manual placental removal 1
  • Never perform digital pelvic examination until placenta previa is excluded 1
  • Never delay delivery beyond 36 weeks in stable patients 1
  • Never deliver at a facility lacking massive transfusion capabilities 1

Risk Factor Context

Understanding risk factors helps identify patients requiring this intensive management approach. The most significant risk is placenta previa with prior cesarean deliveries, present in 49% of placenta accreta spectrum cases. 2 The risk increases dramatically from 3% with placenta previa alone to 11%, 40%, 61%, and 67% for the first, second, third, fourth, and fifth or more cesarean deliveries, respectively. 3 This combination creates abnormal placental location overlying a uterine scar where abnormal invasion is most likely to occur. 2

References

Guideline

Treatment of Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Placenta Accreta Spectrum Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Committee opinion no. 529: placenta accreta.

Obstetrics and gynecology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.